Enhancing Breast Cancer Research Through Snapshot Studies: Benefits and Challenges.

[INTRODUCTION] Snapshot studies have emerged as valuable research design in cancer research, offering rapid, multicenter evaluation of clinical practice on an (inter)national scale. Compared to randomized controlled trials, which are time- and resource-intensive, snapshot studies collect large-scale real-world data in reduced timeframe. In breast cancer care, snapshot studies are particularly effective identifying variations in clinical practice, guideline adherence, and surgical outcomes. Through the MANS and DECIDE studies, nationwide snapshot research on real-world surgical outcomes in breast cancer care is taking shape in the Netherlands.

[METHODS] This article outlines the design and implementation of snapshot studies within breast cancer research as prospective, cross-sectional, multicenter observational design without interventions. Key steps include defining a focused research question, establishing a multidisciplinary steering committee, developing a structured database, and outlining statistical considerations. Participating centers obtain local ethical approval and contribute pseudonymized patient data during a predefined inclusion period. Participation is promoted through coordinated recruitment, and collaborative authorship ensures recognition for all contributors.

[RESULTS] Lessons learned: • Clearly define research questions to prevent data overload and maintain focus. • Early multidisciplinary involvement improves study design and execution. • Structured databases prevent data duplication and inconsistencies. • Common challenges such as workload and data quality can be addressed through standardized templates and proactive communication. • Experience from the MANS and DECIDE studies underline importance of structured planning, consistent data collection and team engagement.

[CONCLUSION] Snapshot studies provide an efficient design for evaluating breast cancer care, as they generate valuable insights into clinical practice and contribute to evidence-based improvements in breast cancer treatment.